Mortality after chronic hepatitis B virus infection: A linkage study involving 2 million parous women from Taiwan

Journal of Infectious Diseases

Volumn 201, Issue 7, 2010, Pages 1016-1023

  Fwu, Chyng Wen ^a   Chien, Yin Chu ^b,c   Nelson, Kenrad E ^a   Kirk, Gregory D ^a   You, San Lin ^b,c   Kuo, Hsu Sung ^d   Feinleib, Manning ^a   Chen, Chien Jen ^b,c  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c GENOMICS RESEARCH CENTER   (Taiwan)

^d CENTER FOR DISEASE CONTROL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ADULT; ARTICLE; BILE DUCT CANCER; CAUSE OF DEATH; CHRONIC HEPATITIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GALLBLADDER CANCER; HEPATITIS B; HETEROZYGOTE; HUMAN; INFECTION PREVENTION; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; PARITY; PREGNANCY; PRENATAL SCREENING; PRIORITY JOURNAL; TAIWAN; VIRUS TRANSMISSION;

ADULT; COHORT STUDIES; FEMALE; HEPATITIS ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; KAPLAN-MEIERS ESTIMATE; MOTHERS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; TAIWAN;

EID: 77749306165     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/651231     Document Type: Article

References (38)

1. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22,707 men in Taiwan. Lancet 1981;2:1129-1133.
2. Han SH. Extrahepatic manifestations of chronic hepatitis B. Clin Liver Dis 2004; 8:403-418.
3. Trepo C, Guillevin L. Polyarteritis nodosa and extrahepatic manifestations of HBV infection; the case against autoimmune intervention in pathogenesis. I Autoimmun 2001; 16:269-274.
4. Guillevin L, Mahr A, Callard P, et al. Hepatitis B virus-associated polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients. Medicine 2005;84:313-322.
5. Ishizaka N, Ishizaka Y, Takahashi E, et al. Increased prevalence of carotid atherosclerosis in hepatitis B virus carriers. Circulation 2002; 105:1028-1030.
6. Moritani M, Adachi K, Arima N, et al. A study of arteriosclerosis in healthy subjects with HBV and HCV infection. J Gastroenterol 2005;40: 1049-1053.
7. Volzke H, Schwahn C, Wolff B, et al. Hepatitis B and C virus infection and the risk of atherosclerosis in a general population. Atherosclerosis 2004;174:99-103. (Pubitemid 38595446)
8. Kuniyoshi M, Nakamuta M, Sakai H, et al. Prevalence of hepatitis B or C virus infections in patients with non-Hodgkin's lymphoma. J Gastroenterol Hepatol 2001;16:215-219.
9. Wang F, Xu RH, Han B, et al. High incidence of hepatitis B virus infection in B-cell subtype non-Hodgkin lymphoma compared with other cancers. Cancer 2007;109:1360-1364. (Pubitemid 46466563)
10. Lim ST, Fei G, Quek R, et al. The relationship of hepatitis B virus infection and non-Hodgkin's lymphoma and its impact on clinical characteristics and prognosis. Eur J Haematol 2007;79:132-137. (Pubitemid 47063256)
11. Park SC, Jeong SH, Kim J, et al. High prevalence of hepatitis B virus infection in patients with B-cell non-Hodgkin's lymphoma in Korea. J Med Virol 2008;80:960-966.
12. Chen MH, Hsiao LT, Chiou TJ, et al. High prevalence of occult hepatitis B virus infection in patients with B cell non-Hodgkin's lymphoma. Ann Hematol 2008; 87:475-480.
13. Ulcickas Yood M, Quesenberry CP Jr, Guo D, et al. Incidence of nonHodgkin's lymphoma among individuals with chronic hepatitis B virus infection. Hepatology 2007; 46: 107-112. (Pubitemid 47171926)
14. Korba BE, Go wans EJ, Wells FV, Tennant BC, Clarke R, Gerin JL. Systemic distribution of woodchuck hepatitis virus in the tissues of experimentally infected woodchucks. Virology 1988; 165: 72-181.
15. Halpern MS, England JM., Deery DT, et al. Viral nucleic acid synthesis and antigen accumulation in pancreas and kidney of Peking ducks infected with duck hepatitis B virus. Proc Natl Acad Sci USA 1983;80: 4865-4869.
16. Fwu CW, Chien YC, Kirk GD, et al. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study. J Natl Cancer Inst 2009; 101:1019-1027.
17. Chen DS, Hsu NH, Sung JL, et al. A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers. JAMA 1987;257:2597-2603.
18. Department of Health, Executive Yuan, R.O.C. (Taiwan). Health and vital statistics. Vol 2. Taiwan: Republic of China, 2005.
19. Chen DS, Sung JL. Hepatitis B virus infection and chronic liver diseases in Taiwan. Acta Hepatogastroenterol 1978; 25:423-430. (Pubitemid 9076288)
20. Chen DS. From hepatitis to hepatoma: lessons from type B viral hepatitis. Science 1993;262:369-370. (Pubitemid 23353374)
21. Chen G, Lin W, Shen F, Iloeje UH, London WT, Evans AA. Chronic hepatitis B virus infection and mortality from non-liver causes: results from the Haimen City cohort study. Int J Epidemiol 2005; 34:132-137. (Pubitemid 40347383)
22. Evans AA, Chen G, Ross EA, Shan F-M, Lin W-Y, London WT. Eightyear follow-up of the 90,000-person Haimen City cohort. I. Hepatocellular carcinoma mortality, risk factors, and gender differences. Cancer Epidemiol Biomarkers Prev 2002; 11:369-376.
23. Ribes J, Cleries R, Rubio A, et al. Cofactors associated with liver disease mortality in an HBsAg-positive Mediterranean cohort: 20 years of follow-up. Int J Cancer 2006;119:687-694. (Pubitemid 43955725)
24. Amin J, Law MG, Bartlett M, Kaldor JM, Dore GJ. Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study. Lancet 2006;368:938-945. (Pubitemid 44331386)
25. Duberg AS, Tömer A, Davidsdóttir L, et al. Cause of death in individuals with chronic HBV and/or HCV infection, a nationwide community-based register study. J Viral Hepat 2008; 15:538-550. (Pubitemid 351798992)
26. Iloeje UH, Yang HI, Jen CL, et al. Risk and predictors of mortality associated with chronic hepatitis B infection. Clin Gastroenterol Hepatol 2007;5:921-931. (Pubitemid 47161142)
27. Lu SN, Su WW, Yang SS, et al. Secular trends and geographic variations of hepatitis B virus and hepatitis C virus-associated hepatocellular carcinoma in Taiwan. Int J Cancer 2006; 119: 1946-1952. (Pubitemid 44356856)
28. Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet Infect Dis 2002; 2:395-1103
29. Department of Health, Executive Yuan, R.O.C. (Taiwan). Health and vital statistics. http://www.doh.gov.tw/CHT2006/DisplayStatisticFile.aspx?d= 68999. Accessed 7 September 2009.
30. Crook PD, Jones ME, Hall AJ. Mortality of hepatitis B surface antigenpositive blood donors in England and Wales. Int J Epidemiol 2003; 32:118-124. (Pubitemid 36503487)
31. Ries LAG, Harkins D, Krapcho M, et al, eds. SEER cancer statistics review, 1975-2003 National Cancer Institute Web site, http:// seer.cancer.gov/csr/1975-2003/results-merged/topic-race-ethnicity .pdf. Published 2006. Accessed 7 September 2009.
32. Bouvard V, Baan R, Straif K, et al. A review of human carcinogens, B. Biological agents. Lancet Oncol 2009; 10:321-322.
33. Pozzato G, Mazzaro C, Crovatto M, et al. Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia. Blood 1994;84:3047-3053. (Pubitemid 24328097)
34. Pasquinelli C, Laure F, Chatenoud L, et al. Hepatitis B virus DNA in mononuclear blood cells. J Hepatol 1986; 3:95-103.
35. Hsing AW, Zhang M, Rashid A, et al. Hepatitis B and C virus infection and the risk of biliary tract cancer: a population-based study in China. Int J Cancer 2008; 122:1849-1853.
36. Qu ZL, Zou SQ, Wei GH, Sun ZC, Wu XZ. In situ nucleic acid detection of HBV X gene in extrahepatic biliary tract carcinomas and its clinicopathological significance. Zhonghua Wai Ke Za Zhi 2004;42:88-91.
37. Hassan MM, Li D, El-Deeb AS, et al. Association between hepatitis B virus and pancreatic cancer. J Clin Oncol 2008; 26:4557-4562.
38. Mason A, Theal J, Bain V, Adams E, Perrillo R. Hepatitis B virus replication in damaged endothelial tissues of patients with extrahepatic disease. Am J Gastroenterol 2005; 100:972-976.